Sydney Lupkin

News

Drugmakers blamed for blocking generics have cost U.S. billions

Author:: Sydney Lupkin

Publish date: May 23, 2018

By delaying development of generics, drugmakers can maintain their monopolies and keep prices high.

News

Patient advocacy groups take in millions from drugmakers. Is there a payback?

Author:: Sydney Lupkin

Publish date: April 6, 2018

KHN launches “Pre$cription for Power,” a groundbreaking database to expose Big Pharma’s ties to patient groups.

News

Climbing cost of decades-old drugs threatens to break Medicaid bank

Author:: Sydney Lupkin

Publish date: August 14, 2017

Skyrocketing price tags for new drugs to treat rare diseases have stoked outrage nationwide. But hundreds of old, commonly used drugs cost the Medi...

News

Drugmakers Dramatically Boosted Lobbying Spending In Trump’s First Quarter

Author:: Sydney Lupkin

Publish date: April 24, 2017

Pharmaceutical companies are “going all in” to fight reduced drug prices and other opposition in Washington.

News

By The Numbers: Trump’s choice for FDA chief is versatile, entrenched in Pharma

Author:: Sydney Lupkin

Publish date: March 15, 2017

President Donald Trump’s pick to lead the Food and Drug Administration has deep ties to the pharmaceutical industry as a consultant, investor, and ...